Both in Pharmaceuticals
Bicycle Therapeutics vs Amarin
Over the past year BCYC returned −52.0% and AMRN returned −18.3%; their daily moves had a correlation of 0.18.
BCYC −52.0% AMRN −18.3%Growth of $1, one year, split-adjusted
| Metric | BCYC | AMRN |
|---|---|---|
| Price | $3.65 | $13.14 |
| Market cap | $255.5M | $277.6M |
| Today | −1.62% | −0.83% |
| 1 month | −13.1% | −5.9% |
| 6 months | −15.9% | −5.8% |
| Year to date | −48.4% | −5.8% |
| 1 year | −50.7% | −17.9% |
| Revenue growth (YoY) | −78.5% | −42.0% |
| Gross margin | 100.0% | 35.5% |
| Net margin | −8002.1% | −18.1% |
| P/E (TTM) | — | — |
| Price / sales | 4.2× | 1.5× |
| Net cash | $510.1M | $314.6M |
| Dividend yield | — | — |
| Volatility (60d) | 40.1% | 23.0% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).